Fundz

Evommune Announces Cash Retention Awards for Executives

PUBLIC · EVMNNov 18, 2026

Position

Chief Financial Officer

Company

Evommune

Kyle Carver
Palo AltoBiotechnologyHealth Care

Description

On November 13, 2026, Evommune's Compensation Committee approved cash retention awards for key executive officers. The awards are designed to incentivize continued employment and are contingent upon certain conditions being met. The amounts include $686,600 for the CEO, $565,000 for the CFO, and $595,000 for the Chief Business & Legal Officer

Quick answer

Evommune Announces Cash Retention Awards for Executives (November 18, 2026). Evommune is based in Palo Alto, California, United States.

What did Evommune announce on November 18, 2026?
On November 13, 2026, Evommune's Compensation Committee approved cash retention awards for key executive officers. The awards are designed to incentivize continued employment and are contingent upon certain conditions being met.
What does Evommune do?
Evommune, Inc. is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases.
Where is Evommune based?
Evommune is based in Palo Alto, California, United States.
Which similar companies made leadership changes around the same time?
CytoDyn (November 18, 2026), Concurrence (November 17, 2026), Procyrion (November 17, 2026) and Verley (November 17, 2026) also announced leadership changes within 45 days of Evommune.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Evommune, and when

A new leader at Evommune brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Evommune raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evommune, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evommune. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evommune

Location

Palo Alto, California, United States

About

Evommune, Inc. is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases. The company is creating game-changing science with the goal of delivering therapies that address symptoms and halt progressive disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evommune changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Luis
Likely contact at this company
••••••••@••••••••

See Luis's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Evommune's next move

Learn about Strategic plan

Evommune changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.